These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody. Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E. J Immunol; 2001 Jun 15; 166(12):7398-403. PubMed ID: 11390491 [Abstract] [Full Text] [Related]
29. Recombinant outer-surface protein A (des-Cys1-OspA) from the Lyme disease spirochete Borrelia burgdorferi: high production levels in Saccharomyces cerevisiae yeast cultures. Mendoza-Vega O, Keppi E, Bouchon B, Nguyen M, Achstetter T. Appl Microbiol Biotechnol; 1996 Jan 15; 44(5):624-8. PubMed ID: 8703433 [Abstract] [Full Text] [Related]
30. Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B. Fikrig E, Tao H, Barthold SW, Flavell RA. Infect Immun; 1995 May 15; 63(5):1658-62. PubMed ID: 7729870 [Abstract] [Full Text] [Related]
32. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Hughes CA, Engstrom SM, Coleman LA, Kodner CB, Johnson RC. Infect Immun; 1993 Dec 15; 61(12):5115-22. PubMed ID: 8225588 [Abstract] [Full Text] [Related]
33. The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator. Kramer MD, Wallich R, Simon MM. Infection; 1996 Dec 15; 24(2):190-4. PubMed ID: 8740121 [Abstract] [Full Text] [Related]
36. Modification of Borrelia burgdorferi to overproduce OspA or VlsE alters its infectious behaviour. Xu Q, McShan K, Liang FT. Microbiology (Reading); 2008 Nov 15; 154(Pt 11):3420-3429. PubMed ID: 18957595 [Abstract] [Full Text] [Related]
37. The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphocytes. Knigge H, Simon MM, Meuer SC, Kramer MD, Wallich R. Eur J Immunol; 1996 Oct 15; 26(10):2299-303. PubMed ID: 8898937 [Abstract] [Full Text] [Related]
38. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B. Norgard MV, Arndt LL, Akins DR, Curetty LL, Harrich DA, Radolf JD. Infect Immun; 1996 Sep 15; 64(9):3845-52. PubMed ID: 8751937 [Abstract] [Full Text] [Related]
39. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. Roehrig JT, Piesman J, Hunt AR, Keen MG, Happ CM, Johnson BJ. J Immunol; 1992 Dec 01; 149(11):3648-53. PubMed ID: 1431134 [Abstract] [Full Text] [Related]
40. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B. Fikrig E, Tao H, Chen M, Barthold SW, Flavell RA. J Clin Invest; 1995 Oct 01; 96(4):1706-14. PubMed ID: 7560061 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]